64Cu-Labeled Peptide for PET of Breast Carcinomas Expressing the Thomsen-Friedenreich Carbohydrate Antigen
Open Access
- 7 October 2011
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 52 (11) , 1819-1826
Abstract
Thomsen-Friedenreich (TF) antigen is a disaccharide, galactose β1-3 N-acetylgalactosamine (Galβ1-3GalNAc), expressed on the cell surfaces of most human carcinomas including breast. In this study, we synthesized and evaluated the in vitro and in vivo properties of a 64Cu-radiolabeled TF antigen–specific peptide derived from bacteriophage display for the purpose of breast tumor targeting and PET of human breast tumors in xenografted mice. Methods: The TF antigen–specific peptide IVWHRWYAWSPASRI was synthesized with the chelator 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) at the amino terminus, followed by a Gly-Ser-Gly (GSG) spacer. Amino acids Asp and Arg were introduced at both ends to enhance its solubility. Purified NO2A-GSG-DRD-IVWHRWYAWSPASRI-DRD (NO2A-TFpep) was radiolabeled with 64Cu and evaluated for binding to human MDA-MB-435 breast cancer cells, 50% inhibitory concentration (IC50), and serum stability. In vivo pharmacokinetic and small-animal PET studies were performed using SCID mice bearing MDA-MB-435 tumor xenografts. Results: 64Cu-NO2A-TFpep bound to human MDA-MB-435 breast carcinoma cells, whereas almost no binding was observed to normal human breast 184A1 cells. The peptide exhibited an apparent IC50 value of 70 ± 8.0 nM. In vivo biodistribution studies indicated radiolabeled peptide accumulation in tumors of MDA-MB-435 xenografted SCID mice of approximately 1.10 ± 0.20 percentage injected dose per gram (%ID/g) and 0.90 ± 0.12 %ID/g, at 0.5 and 1 h, respectively. Accumulation of radioactivity was low in other organs, with the exception of liver (1.52 ± 0.12 %ID/g) and kidneys (15.4 ± 1.73 %ID/g) at 1 h. Live imaging studies with 64Cu-NO2A-TFpep (15 MBq) demonstrated good tumor uptake at 1 h after injection, whereas no tumor uptake was observed with a scrambled radiolabeled peptide 64Cu-NO2A-GSG-DRD-RWSWWAVHRIPYSAI-DRD. Conclusion: 64Cu-NO2A-TFpep may function as a noninvasive in vivo tumor imaging agent of human breast and other carcinomas expressing the TF carbohydrate antigen. This is the first such TF antigen–targeting peptide used in tumor imaging.Keywords
This publication has 26 references indexed in Scilit:
- Carbohydrate antigens in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsyBMC Cancer, 2010
- 18F, 64Cu, and 68Ga Labeled RGD-Bombesin Heterodimeric Peptides for PET Imaging of Breast CancerBioconjugate Chemistry, 2009
- Improving Tumor Uptake and Pharmacokinetics of 64Cu-Labeled Cyclic RGD Peptide Dimers with Gly3 and PEG4 LinkersBioconjugate Chemistry, 2009
- Tumor immunolocalization using 124I-iodine-labeled JAA-F11 antibody to Thomsen–Friedenreich alpha-linked antigenApplied Radiation and Isotopes, 2008
- [ 64 Cu-NOTA-8-Aoc-BBN(7-14)NH 2 ] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissuesProceedings of the National Academy of Sciences, 2007
- In Vitro and in Vivo Evaluation of 64Cu-Labeled DOTA−Linker−Bombesin(7−14) Analogues Containing Different Amino Acid Linker MoietiesBioconjugate Chemistry, 2007
- Thomsen-Friedenreich and Tn Antigens in Nipple Fluid: Carbohydrate Biomarkers for Breast Cancer DetectionClinical Cancer Research, 2005
- Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinomaCancer, 2000
- Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display librariesJournal of Molecular Biology, 1997
- A New Monoclonal Antibody (A78-G/A7) to the Thomsen—Friedenreich Pan-Tumor AntigenHybridoma, 1995